نتائج البحث - "Muscarinic antagonist"

1

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

المؤلفون: Wen-Chien Cheng, Wu-Huei Hsu, Chih-Yu Chen, Biing-Ru Wu, Wei Chun Chen, Chia-Hung Chen, Chih Yen Tu, Te Chun Hsia, Wei-Chih Liao

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: long-acting β2 agonist, medicine.medical_specialty, Multivariate analysis, medicine.drug_class, LABA, Muscarinic Antagonists, Disease, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, CID, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, Administration, Inhalation, long-acting muscarinic antagonist, COPD, Humans, Medicine, 030212 general & internal medicine, chronic pulmonary obstructive disease, Adrenergic beta-2 Receptor Agonists, Original Research, clinically important deterioration, Retrospective Studies, biology, Receiver operating characteristic, business.industry, LAMA, Muscarinic antagonist, General Medicine, Lama, biology.organism_classification, medicine.disease, Bronchodilator Agents, 030228 respiratory system, ICS, triple therapy, Ics laba, Disease Progression, Corticosteroid, Drug Therapy, Combination, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d1c3a1c43ae6a1bb67ff4d5df786a6Test
https://doi.org/10.2147/copd.s279482Test

2

Outcomes of Antibiotics in Adults with 'Difficult to Treat' Asthma or the Overlap Syndrome

المؤلفون: Fred A Wagshul, Nikki M Schultek, David L Hahn, Doris T Brown

المصدر: Journal of Asthma and Allergy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50aa09b36b4f2eb6ec6596ca2947b5adTest
https://doi.org/10.2147/jaa.s313480Test

3

A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand

المؤلفون: Raewyn J Scott, Tim Holbrook, Brett Marett, Robert P. Young, Dominique Milea, Anthony Braganza, Barry Gribben, Xiaomeng Xu, Aldo Amador Navarro Rojas

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, long-acting β-agonist, Treatment duration, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, chronic obstructive pulmonary disease, Persistence (computer science), Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, multiple-inhaler triple therapy, Internal medicine, Bronchodilator, Administration, Inhalation, Humans, long-acting muscarinic antagonist, Medicine, 030212 general & internal medicine, Medical prescription, Adrenergic beta-2 Receptor Agonists, Aged, Retrospective Studies, Original Research, COPD, business.industry, Nebulizers and Vaporizers, Inhaler, Mean age, General Medicine, medicine.disease, Bronchodilator Agents, 030228 respiratory system, Corticosteroid, Drug Therapy, Combination, business, New Zealand

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5fba999363668a6349da1d05c016efTest
https://doi.org/10.2147/copd.s295183Test

4

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers

المؤلفون: Jessica Franchino-Elder, Ami R Buikema, David Singer, Caitlin A Elliott, Lindsay G S Bengtson

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Medicare, Patient Readmission, chronic obstructive pulmonary disease, soft mist inhaler, readmissions, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, dry powder inhaler, exacerbations, Internal medicine, Administration, Inhalation, medicine, COPD, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Adrenergic beta-2 Receptor Agonists, Asthma, Original Research, healthcare resource utilization, Aged, SMI, business.industry, Inhaler, LAMA, Dry Powder Inhalers, General Medicine, Odds ratio, medicine.disease, Confidence interval, Dry-powder inhaler, United States, Discontinuation, Bronchodilator Agents, DPI, 030228 respiratory system, Cohort, Disease Progression, Female, business, Delivery of Health Care

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5802e00c24becf505175d25f83402e14Test
http://europepmc.org/articles/PMC7732756Test

5

First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease

المؤلفون: Makoto Yoshida, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Ayako Takamori, Shinichiro Hayashi, Hiroki Tashiro, Takashi Kinoshita, Hiroshi Inoue, Keisuke Kojima, Ryo Tajiri, Koichiro Takahashi, Go Kato, Tomotaka Kawayama, Masahide Tanaka, Shinya Kimura, Hiromi Kobayashi, Masaru Uchida, Hironori Sadamatsu

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Spirometry, Male, medicine.medical_specialty, medicine.drug_class, Physical activity, physical activity, Metabolic equivalent, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Bronchodilator, Internal medicine, Forced Expiratory Volume, medicine, Humans, long-acting muscarinic antagonist, In patient, 030212 general & internal medicine, Prospective Studies, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Exercise, Lung, Aged, Original Research, COPD, medicine.diagnostic_test, business.industry, Olodaterol, General Medicine, Middle Aged, medicine.disease, Benzoxazines, Bronchodilator Agents, respiratory tract diseases, Drug Combinations, Treatment Outcome, 030228 respiratory system, chemistry, Cardiology, Female, long-acting beta 2 agonist, business, Body mass index, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25992fa836e3ce7f10cca83afc16dd00Test
http://europepmc.org/articles/PMC7501469Test

6

Forced Expiratory Flow (FEF25–75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis

المؤلفون: John Given, Branko Jugovic, Stanley J. Szefler, Stanley Goldstein, Eckard Hamelmann, George W Bensch, Christian Vogelberg, Ralf Sigmund, Michael Engel, P. Moroni-Zentgraf

المصدر: Pulmonary Therapy, Vol 6, Iss 2, Pp 151-158 (2020)
Pulmonary Therapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2a380496d24d72d808e896f008b6b2Test
https://doi.org/10.1007/s41030-020-00117-6Test

7

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies

المؤلفون: Colin Reisner, Klaus F. Rabe, Martin Jenkins, Brian Lipworth, Ubaldo J. Martin, Fernando J. Martinez, Samir Arora

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Exacerbation, bronchodilator, muscarinic antagonist, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Formoterol Fumarate, Bronchodilator, β2- agonist, Multicenter Studies as Topic, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, education.field_of_study, COPD, integumentary system, co-suspension delivery technology, General Medicine, Middle Aged, Metered-dose inhaler, Obstructive lung disease, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Female, medicine.medical_specialty, medicine.drug_class, Population, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Metered Dose Inhalers, education, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, lung function, Recovery of Function, medicine.disease, Glycopyrrolate, Clinical Trials, Phase III as Topic, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168165fcd6c39542bd6a0b409b60d3ecTest
https://doi.org/10.2147/copd.s229794Test

8

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

المؤلفون: Eric Bourne, Gary T. Ferguson, Yoshikazu Inoue, Kiernan DeAngelis, Hiroshi Okada, Nobuya Hayashi, Masakazu Ichinose, Osamu Hataji, Klaus F. Rabe, Shaila Ballal, Paul Dorinsky, Magnus Aurivillius, Yasushi Fukushima, Colin Reisner, Mami Takikawa

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Budesonide, Male, medicine.medical_specialty, Population, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, Severity of Illness Index, Time, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Japan, Double-Blind Method, Internal medicine, Formoterol Fumarate, medicine, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Metered Dose Inhalers, long-acting β2-agonist, education, Original Research, COPD, education.field_of_study, integumentary system, business.industry, co-suspension delivery technology, ICS/LAMA/LABA, General Medicine, Drug Tolerance, Middle Aged, medicine.disease, Metered-dose inhaler, Glycopyrrolate, Dry-powder inhaler, Bronchodilator Agents, Respiratory Function Tests, Drug Combinations, Treatment Outcome, 030228 respiratory system, Tolerability, Bronchitis, Female, Drug Monitoring, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cebea17bf9328c5d1ee322ed65c26717Test
http://europepmc.org/articles/PMC6934178Test

9

Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease

المؤلفون: Shuchita Kaila, Mary DuCharme, Swetha R Palli, Ami R Buikema, Monica Frazer, Timothy Juday

المصدر: Journal of Comparative Effectiveness Research. 8:1299-1316

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.drug_class, Pulmonary disease, Muscarinic Antagonists, Medicare, Inverse probability of treatment weighting, Insurance Claim Review, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, medicine, Humans, 030212 general & internal medicine, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Aged, Aged, 80 and over, COPD, business.industry, β2 agonists, Health Policy, Tiotropium-olodaterol, Muscarinic antagonist, Pneumonia, Middle Aged, medicine.disease, United States, Benzoxazines, Bronchodilator Agents, Drug Combinations, Models, Economic, Treatment Outcome, 030228 respiratory system, Disease Progression, Corticosteroid, Drug Therapy, Combination, Female, Health Expenditures, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697ad907cac43d84a5f2294535f4433dTest
https://doi.org/10.2217/cer-2019-0101Test

10

Methacholine challenge testing: comparative pharmacology

المؤلفون: Christianne M. Blais, Beth E. Davis, Donald W. Cockcroft

المصدر: Journal of Asthma and Allergy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f226ca7ebedb14db198adfa3cb9b22dTest
https://doi.org/10.2147/jaa.s160607Test

تنقيح النتائج